AstraZeneca

The biocompatible polymers market, valued at USD 957 million in 2023, is projected to reach USD 1,847.7 million by 2033, driven by healthcare advancements, particularly in medical implants, drug delivery systems, and tissue engineering. North America leads the market, while Asia-Pacific is expected to grow significantly. Key applications include medical devices, drug delivery systems, tissue engineering, and prosthetics. Biodegradable polymers are expanding the market's scope. Evonik Industries AG is the largest vendor.

Mike Peters, frontman of The Alarm, diagnosed with aggressive Richter’s syndrome, saw his cancer disappear after participating in a clinical trial combining acalabrutinib with chemotherapy at The Christie NHS Foundation Trust. Now in complete remission, he plans to undergo a donor stem cell transplant for a chance at a cure.

Innate Pharma SA will co-host a hybrid scientific symposium on October 3, 2024, with Mount Sinai, featuring key opinion leaders in immunotherapy. The event marks Innate Pharma's 25th anniversary and highlights next-generation immunotherapy discoveries.

Mike Peters, frontman of The Alarm, is in remission from aggressive cancer after participating in an NHS drug trial. Diagnosed with Richter's syndrome, he was given a couple of months to live but responded well to a combination of acalabrutinib and chemotherapy. Peters now seeks a stem cell transplant to prevent recurrence.

Familial chylomicronemia syndrome (FCS) lacks approved therapies, but olezarsen and plozasiran show promise in phase 3 trials. Olezarsen, an antisense oligonucleotide, and plozasiran, a small interfering RNA, both demonstrated significant triglyceride reduction and reduced pancreatitis risk in FCS patients.

The article discusses the importance of SSR (Server-Side Rendering) in modern web development, emphasizing its role in improving performance and user experience.

MP Nigdelis received honoraria from RG Ärztefortbildung GmbH and travel grants from Organon and Gedeon Richter. M Doerk received travel grants from Gedeon Richter, Organon, and Eisai, and is a member of DGGG, AGE, and Deutsche Gesellschaft für Senologie. S Burghaus received honoraria from FOMF and is a member of DGGG, AGEM, AGE, Stiftung Endometriose Forschung, AGUB, AGO, and DKK. M Sillem, CEO of EuroEndoCert Gmbh, received payments from Bayer, Gedeon Richter, Hologic, and EndoHealth. B Haj Hamoud received travel grants from Gedeon Richter, Astrazeneca, Johnson & Johnson, and Storz, and is a member of DGGG, AGE, and Stiftung Endometriose Forschung. EF Solomayer receives grants from the University of Saarland, Storz, and Erbe, and fees from Roche, Pfizer, Celgene, Amgen, Astra Zeneca, Esai, Johnson & Johnson, Novartis, Tesaro, Teva, Medac GmbH, MSD, Vifor, Gedeon Richter, Takeda, and AGE, among others. GL Olmes received grants from AstraZeneca, Universitätsklinikum Freiburg, and RG Ärztefortbildung GmbH, and is a member of DGGG, AGE, and AGEM, with scientific collaboration with Karl Stotz.

Fred Hutch Cancer Center study shows industry-sponsored cancer clinical trials enroll over eight times more patients than federally sponsored trials, revealing underinvestment in federal research and growing reliance on industry.

AstraZeneca's Discovery Centre, built by Mace Group, will be a new HQ and lab complex for 2,000 employees in Cambridge, UK, focusing on oncology, cardiovascular, renal and metabolism, and respiratory diseases. The centre aims to harness AI and data for new medical discoveries, with Mace Operations Director John Kiuthi emphasizing the project's significance for future science.

Global medical giants, including AstraZeneca and BGI, showcased digital healthcare innovations at the third Global Digital Trade Expo in Hangzhou. AstraZeneca launched a New Customer Engagement Platform with Tencent Healthcare and developed AI tools with Alibaba Cloud. BGI demonstrated DNA storage technology, highlighting its high data storage density. Both companies emphasized the integration of digital intelligence in healthcare, aligning with the expo's focus on AI applications in medicine.